CF PHARMTECH, Inc. (Stock Code: 02652) has set 30 March 2026 for a board meeting to review and approve the consolidated financial results for the fiscal year ended 31 December 2025. The agenda also includes deliberation on a potential final dividend and other corporate matters.

The meeting will be chaired by Dr. Liang Bill Wenqing, who serves as Chairperson, Executive Director and Chief Executive Officer. The current board comprises four executive directors, three non-executive directors and four independent non-executive directors.

No additional financial figures or dividend details were disclosed in the announcement dated 18 March 2026.